Stay updated on Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.

Latest updates to the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new revision line (Revision: v3.6.5) was added, and a large set of institutional names, investigator names, sponsor/collaborator references, and MeSH/keywords were removed, altering the displayed affiliations, contributors, and metadata for the study page.SummaryDifference20%

- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- The page revision tag changed to v3.6.4, indicating a new revision of the study details page.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision label was updated to v3.6.3, signaling a newer version of the page content.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.6.2 is now displayed on the page, indicating a minor update to the page's system or template rather than changes to the study data.SummaryDifference0.1%

- Check58 days agoChange DetectedSeveral reader-facing sections were added (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) to aid understanding and participation; the Intervention/Treatment label was reformatted and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page's revision stamp has been updated from v3.5.4 to v3.5.5, signaling a minor maintenance update to the page template rather than a change to study content.SummaryDifference0.1%

Stay in the know with updates to Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine with Pembrolizumab in Metastatic Melanoma Clinical Trial page.